Hosted on MSN1mon
FDA Accepts Bayer's Application for Label Expansion of NubeqaBayer BAYRY announced that the FDA has accepted its supplemental new drug application (sNDA) for Nubeqa (darolutamide). The sNDA is seeking label expansion ... and the regulatory body has set ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback